Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Melanoma Res. 2022 Apr 1;32(2):88–97. doi: 10.1097/CMR.0000000000000796

Figure 3 –

Figure 3 –

Detection of gp100 specific IgG antibody was variable across patients in the study and had no obvious pattern associated with vaccination. The antibody titers of all available samples were recorded with a variable baseline presence of antibody responses noted (A). Comparison of responders (Pt01 and Pt02) versus non-responders did not exhibit any correlation to clinical outcomes or response to vaccination (B).